Home › Amblyopia › Illinois › Naperville
Amblyopia clinical trials in Naperville, IL
4 studies for Amblyopia are looking for participants at sites in and around Naperville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
RecruitingPhase 3
- Progressive Eye Care, Lisle · 4 mi away
- Midwestern University Eye Institute, Downers Grove · 7 mi away
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RecruitingPhase 3
- Progressive Eye Care, Lisle · 4 mi away
- Midwestern University Eye Institute, Downers Grove · 7 mi away
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RecruitingPhase 3
- Progressive Eye Care, Lisle · 4 mi away
- Midwestern U Chicago College of Optometry, Downers Grove · 7 mi away
Noninvasive Brain Stimulation in Adult Amblyopia
RecruitingHealthy volunteers welcome
- Midwestern University Eye Institute, Downers Grove · 7 mi away
About Amblyopia
Learn about amblyopia, or "lazy eye," the most common cause of visual problems in children. It happens when an eye fails to work properly with the brain.
More about Amblyopia on MedlinePlus
Amblyopia trials in other cities
- Baltimore, MD4 studies
- Dallas, TX4 studies
- Boston, MA4 studies
- Philadelphia, PA4 studies
- New York City, NY4 studies
- Chicago, IL4 studies
- Erie, PA3 studies
- Sacramento, CA3 studies
- Cincinnati, OH3 studies
- Mountain View, CA3 studies
- Irvine, CA3 studies
- Durham, NC3 studies
Other studies in Naperville
- Non-Small Cell Lung Cancer15 studies
- Lung Cancer13 studies
- Heart Failure11 studies
- Breast Cancer10 studies
- Prostate Cancer10 studies
- Cardiovascular Disease8 studies
- Pancreatic Cancer6 studies
- Macular Degeneration6 studies
- Geographic Atrophy6 studies
- Colon Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Atrial Fibrillation5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.